Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 1710138 | LTURM-34 | 1879887-96-3 | >98% |  |
| LTURM-34 is a novel potent and selective DNA-PK inhibitor, attenuating proliferation | ||||
| 1710137 | LY2606368 dihydrochloride | 1234015-54-3 | >98% |  |
| Prexasertib (LY2606368) is an ATP-competitive CHK1 inhibitor with a Ki value of 0.9 n | ||||
| 179301 | LDC1267 | 1361030-48-9 | >98% |  |
| LDC1267 markedly reduced murine mammary cancer and melanoma metastases dependent on N | ||||
| 1791119 | Lavendustin C | 125697-93-0 | 98.0% |  |
| Lavendustin C, also known as HDBA and NSC 666251, is a potent inhibitor of epidermal | ||||
| 52025 | Lenvatinib (E7080) | 417716-92-8 | 98% | -cas-417716-92-8.png) |
| Lenvatinib, also known as E7080, is a synthetic, orally available inhibitor of vascul | ||||
| 1781108 | LXS-196 | 1874276-76-2 | 98.0% |  |
| <span style="color:#34495E;font-family:"font-size:14px;background-color: | ||||
| 178902 | LDC4297(LDC044297) | 1453834-21-3 | 98.0% | -cas-1453834-21-3.png) |
| LDC4297,also known as LCD044297,is a potent and selective CDK7 inhibitor. | ||||
| 2017887 | LY3214996 | 1951483-29-6 | 98.0% |  |
| LY-3214996 is a potent and selective, orally available inhibitor of extracellular sig | ||||
| 20178218 | LTX-315 | 1345407-05-7 | 98% |  |
| LTX-315 is an amphipathic cationic peptide potentially for the treatment of melanoma, | ||||
| 20178212 | LY 344864 | 186544-26-3 | 98.0% |  |
| LY344864 is a selective 5-HT1F receptor agonist with an affinity of 6 nM (Ki) at the | ||||
| 2017828 | LY 344864 hydrochloride | 1217756-94-9 | 98.0% |  |
| LY344864 hydrochloride is a potent and selective 5-HT1F receptor agonist. It has an E | ||||
| 17030102 | Lys05 trihydrochloride | 1391426-24-6 | 98% | |
| Lys05, or Lys01 trihydrochloride, is a potent, water soluble lysosomal autophagy inhi | ||||
| 17022807 | Lapatinib | 231277-92-2 | 98% |  |
| Lapatinib(GW-572016) is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 n | ||||
| 17022706 | Lesinurad | 878672-00-5 | 98% |  |
| Lesinurad(RDEA594), once-daily inhibitor of URAT1, is a transporter in the kidney tha | ||||
| 17021601 | LY3039478 ( Crenigacestat ) | 1421438-81-4 | ≧98.0% |  |
| LY3039478 ( Crenigacestat ), a selective NOTCH1 inhibitor, reduces intrahepatic chola | ||||
| 17021314 | LCI699 | 928134-65-0 | 98% | |
| LCI699(Osilodrostat) is a potent inhibitor of 11-hydroxylase, an enzyme catalyzing t | ||||
| 17012102 | lumateperone(Tosylate) | 1187020-80-9 | 98% | _1187020-80-9.png) |
| Lumateperone (ITI-722/ITI-007) is a novel, first-in-class dual 5HT2A receptor antagon | ||||
| 16123043 | Lys05 | 1391426-22-4 | 98% |  |
| Lys05 is a potent lysosomal autophagy inhibitor. Lys05 is a previously undescribed di | ||||
| 16123042 | LY-3177833 | 1627696-51-8 | 98% | |
| LY-3177833 is a potent and selective inhibitor of CDC7 (Cell Division Cycle 7-related | ||||
| 16123041 | LY3009120 | 1454682-72-4 | 98% | |
| LY3009120, also known as DP-4978, is potent and selective pan-RAF inhibitor with pote | ||||
| 16123040 | LY2334737 | 892128-60-8 | 98% | |
| LY2334737 is an orally available valproic acid ester of gemcitabine, a broad-spectrum | ||||
| 16123039 | LY2109761 | 700874-71-1 | 98% |  |
| LY2109761 is a novel transforming growth factor beta receptor type I and type II dual | ||||
| 16123038 | Luliconazole | 187164-19-8 | 98% |  |
| Luliconazole is an azole antifungal drug. As a 1% topical cream, luliconazole is indi | ||||
| 16123037 | Lubiprostone | 333963-40-9 | 98% |  |
| Lubiprostone, also known as RU-0211, is a medication used in the management of chroni | ||||
| 16123036 | LOXO-101 (ARRY-470) | 1223403-58-4 | 98% | -cas-1223403-58-4.png) |
| Larotrectinib, also known as ARRY-470 and LOXO-101, is an orally bioavailable, potent | ||||
| 16123035 | Lomitapide free base | 182431-12-5 | 98% |  |
| Lomitapide is a MTP inhibitor. Lomitapid is a novel agent for the treatment of homozy | ||||
| 16123034 | Lometrexol disodium | 106400-81-1 | 98% |  |
| Lometrexol is a folate analog antimetabolite with antineoplastic activity. As the 6R | ||||
| 16123033 | LGK974 (WNT974) | 1243244-14-5 | 98% | -cas-1243244-14-5.png) |
| LGK974, aslo known as is a selective and orally bioavailable Porcupine (PORCN) inhibi | ||||
| 16123031 | Levobupivacaine free base | 27262-47-1 | 98% |  |
| Levobupivacaine is a local anaesthetic drug belonging to the amino amide group. It is | ||||
| 16122828 | L67 | 325970-71-6 | 98% | |
| L67 is a DNA Ligase Inhibitor. L67 inhibited DNA ligases I and III. L67 is a simple c | ||||